Abstract
Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Current Genomics
Title: Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer
Volume: 1 Issue: 1
Author(s): I. Sanchez-Garcia
Affiliation:
Keywords: Translocation-Associated Genes, Proto oncogenes, Tumor suppressor genes, DNA repair Enzymes, Chromosomal translocations, Oncogenes, Human Cancer, DNA rearrangement, Gene amplification, Lineage
Abstract: Cancer results from subversion of the processes that control the normal growth, location and mortality of cells. This loss of normal control mechanisms arises from the acquisition of mutations in three broad categories of genes proto-oncogenes, tumor suppressor genes and DNA repair enzymes. Proto-oncogene activation may occur by mutation, gene amplification or DNA rearrangement. Chromosomal translocations entail the generation of gene fusions in both haematopoietic and solid mesenquimal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype is pending to understand. The application of transgenic methods to the study of these cancer-associated gene fusions have provided insights into their in vivo functions and suggested mechanisms by which lineage selection may be achieved. Herein these studies are reviewed to illustrate how manipulation of their loci in the mouse has co ntributed to current understanding in unique and unexpected ways.
Export Options
About this article
Cite this article as:
Sanchez-Garcia I., Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351814
DOI https://dx.doi.org/10.2174/1389202003351814 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Cancer Therapy; Nanotechnology Approaches for Overcoming Drug Resistance
Current Medicinal Chemistry Immunotherapy for Myeloproliferative Neoplasms (MPN)
Current Cancer Drug Targets Occurrence and Biological Properties of Sphingolipids - A Review
Current Nutrition & Food Science Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
Current Cancer Drug Targets MicroRNA-203: Tumor Suppression and Beyond
MicroRNA Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Cutoff Values of D-Dimer and FDP in Plasma for the Diagnosis of Thrombosis
Vascular Disease Prevention (Discontinued) Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Pro-inflammatory Cytokines in Animal and Human Gestation
Current Pharmaceutical Design ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update
Current Topics in Medicinal Chemistry NBS1 Heterozygosity and Cancer Risk
Current Genomics Opportunities and Challenges for Host-Directed Therapies in Tuberculosis
Current Pharmaceutical Design Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia
Current Medicinal Chemistry Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Making Sense of Molecular Signatures in The Immune System
Combinatorial Chemistry & High Throughput Screening The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
Current Stem Cell Research & Therapy Activated Cancer Therapy Using Light and Ultrasound - A Case Series of Sonodynamic Photodynamic Therapy in 115 Patients Over a 4 Year Period
Current Drug Therapy Hypoxia-Inducible Factors and Sphingosine 1-Phosphate Signaling
Anti-Cancer Agents in Medicinal Chemistry Preclinical Studies of PROTACs in Hematological Malignancies
Cardiovascular & Hematological Disorders-Drug Targets Caffeic Acid Phenethyl Ester Effects: In Silico Study of its Osteoimmunological Mechanisms
Letters in Drug Design & Discovery